M. A. ÖZGÜN Et Al. , "1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study," ESMO 2021 , vol.32, pp.892, 2021
ÖZGÜN, M. A. Et Al. 2021. 1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study. ESMO 2021 , 892.
ÖZGÜN, M. A., DOĞAN, İ., KARAKURT ERYILMAZ, M., ERDOĞAN, A. P., AYHAN, M., HAFIZOĞLU, E., ... KUBİLAY, P.(2021). 1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study . ESMO 2021 (pp.892).
ÖZGÜN, MEHMET Et Al. "1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study," ESMO 2021, 2021
ÖZGÜN, MEHMET A. Et Al. "1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study." ESMO 2021 , pp.892, 2021
ÖZGÜN, M. A. Et Al. (2021) . "1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study." ESMO 2021 , p.892.
@conferencepaper{conferencepaper, author={MEHMET ALPASLAN ÖZGÜN Et Al. }, title={1076P Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study}, congress name={ESMO 2021}, city={}, country={}, year={2021}, pages={892} }